Market Cap
2797569280.00
RXRX
Recursion Pharmaceuticals, Inc.
Exchange: nyse
Multiples
- P/E: -7.41
- P/BV: 3.91
- P/TBV: 6.80
Description:
RXRX is the ticker symbol for the Recro Pharma, Inc., a company listed on the New York Stock Exchange (NYSE). However, it appears there might be some confusion as the ticker RXRX actually refers to REGENXBIO Inc., a gene therapy company that develops genetic medicines. REGENXBIO focuses on leveraging its proprietary NAV Technology Platform to transform genetic medicine into a new generation of treatments for patients suffering from serious diseases. The company's efforts are centered around delivering these therapies through vectors that can effectively and safely deliver genes to targeted tissues in the body.
Data:
Yields:
Earnings Yield
1.080493306349
Return on Capital
-5.586493863525
CAGR (net income)
0%
CAGR Length
0
Dividend Rate
